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Defective antibody production in aging is broadly
attributed to immunosenescence. However, the pre-
cise immunological mechanisms remain unclear.
Here, we demonstrate an increase in the ratio of
inhibitory T follicular regulatory (TFR) cells to stimula-
tory T follicular helper (TFH) cells in aged mice. Aged
TFH and TFR cells are phenotypically distinct from
those in young mice, exhibiting increased pro-
grammed cell death protein-1 expression but
decreased ICOS expression. Aged TFH cells exhibit
defective antigen-specific responses, and pro-
grammed cell death protein-ligand 1 blockade can
partially rescue TFH cell function. In contrast, young
and aged TFR cells have similar suppressive capac-
ity on a per-cell basis in vitro and in vivo. Together,
these studies reveal mechanisms contributing to
defective humoral immunity in aging: an increase in
suppressive TFR cells combined with impaired func-
tion of aged TFH cells results in reduced T-cell-
dependent antibody responses in aged mice.
INTRODUCTION
It is well known that the extent of humoral immunity, or immunity
provided by antibodies, decreases with age in bothmice and hu-
mans (Goidl et al., 1976; Phair et al., 1978). This decrease in hu-
moral immunity translates into increased frequency and severity
of infectious diseases in aged individuals. Furthermore, vaccina-
tion of the elderly provides inadequate protection against most
infectious diseases, leaving these individuals vulnerable to a
number of diseases (Goronzy and Weyand, 2013; Sasaki et al.,
2011).
The production of high-affinity antibodies results from a com-
plex interaction of B cells with T follicular helper (TFH) cells in the
germinal center (GC) reaction. After differentiation, CXCR5+ TFHcells migrate to the B cell follicle via gradients of CXCL13 and
provide help to B cells via costimulation and cytokine production
(Crotty, 2011). Mice lacking TFH cells, or their key effector mol-
ecules, have severely defective antibody production in response
to T-dependent antigens.
T follicular regulatory (TFR) cells are a recently defined special-
ized subset of effector T regulatory cells (Tregs) that inhibit anti-
body production (Chung et al., 2011; Linterman et al., 2011; Sage
et al., 2013;Wollenberg et al., 2011). TFR cells originate from nat-
ural Tregs (Chung et al., 2011; Sage et al., 2013) in contrast to
TFH cells, which develop from naive CD4+ T cell precursors.
Similar to TFH cells, TFR cells express CXCR5, ICOS, and pro-
grammed cell death protein-1 (PD-1), as well as the transcription
factor Bcl6. PD-1 expression on TFR cells limits both the differ-
entiation and effector function of TFR cells (Sage et al., 2013).
How TFR cells exert their suppressive effects is not yet clear.
We have demonstrated that the ratio of TFH/TFR cells is an
important factor in humoral immunity and that this ratio dictates
the magnitude of antibody responses (Sage et al., 2013, 2014a).
Therefore, successful humoral immunity is a delicate balance
between stimulatory TFH cells and inhibitory TFR cells and not
simply a result of the total number of TFH cells. TFR cells appear
to be specialized in their suppression of theGC reaction because
non-TFR Tregs do not have the same suppressive capacity
(Sage et al., 2013, 2014a, 2014b).
The precise mechanisms leading to poor B cell responses in
the aged are not understood. In 1969, Walford used the term im-
munosenescence to describe the decline in the immune system
with age. In the T cell compartment, thymic involution, leading to
reduction in the output of naive T cells in the elderly, is one hy-
pothesized cause of immune system decline (Scollay et al.,
1980). Reduced naive cell output also occurs in the B cell
compartment (Miller and Allman, 2003). Additionally, there are al-
terations in the ability of naive lymphocytes to become activated
and form memory cells (Haynes et al., 2003; Linton and Dorsh-
kind, 2004). Some, but not all, of these changes can be rescued
by addition of interleukin-2 (IL-2) because IL-2 production is
attenuated with age (Haynes et al., 1999). There are also
increased numbers of natural Tregs in lymphoid organs (butCell Reports 12, 163–171, July 14, 2015 ª2015 The Authors 163
not the blood) (Jagger et al., 2014). It is not yet clear if Tregs from
aged individuals are equally or more suppressive compared to
Tregs from younger individuals (Nishioka et al., 2006; Raynor
et al., 2012).
Although a number of studies have assessed the total CD4+
T cell and Treg populations in the aged, it is still unclear if alter-
ations exist in TFH and TFR cells. A previous study found no dif-
ference in CXCR5+ cells in aged mice; however, TFR cells were
not examined (Eaton et al., 2004). A recent study found slight in-
creases in TFH cells in the blood of aged human subjects, but
TFR cells were not evaluated (Zhou et al., 2014). Understanding
changes in TFH and TFR cells during aging is important because
both of these cell types directly interact with cognate B cells and
control antibody production.
In this study, we compared TFH and TFR cell development and
function in young and aged mice. We find increases in both TFH
and TFR cells in aged mice, with a proportionally greater in-
crease in TFR cells. We also show that TFH cells from aged
mice have defects in antigen-specific B cell stimulation. Aged
and young TFR cells, however, have comparable suppressive
capacity. Thus, our studies reveal a mechanism that attenuates
antibody responses in the aged: the over-abundance of highly
suppressive TFR cells in aged mice and the inability of TFH cells
to respond effectively to specific antigens result in an overall
decrease in B cell responses.
RESULTS AND DISCUSSION
Increased TFR Cell Polarization in Aged Mice
To determine if alterations in TFH and TFR cells contribute to
defective antibody production in aged mice, we first compared
antibody production in 2-month-old (young) and 20-month-old
(aged) mice 10 days after subcutaneous (s.c.) immunization
with NP-OVA in Freund’s complete adjuvant (CFA). Aged mice
had greater total serum concentrations of IgM and IgG than
young mice; however, NP-specific IgG (but not IgM) antibody ti-
ters were significantly lower (Figure 1A). Lower antigen-specific
IgG was also seen in aged mice 27 days after immunization (Fig-
ure S1B). Together, these data indicate that aged mice produce
less antigen-specific antibody following immunization.
Next, we determined whether TFH and/or TFR cells were
altered in aged mice. First, we compared TFH and TFR cells
without immunization. TFH cells, defined as CD4+ICOS+CXCR5+
FoxP3CD19 cells, were low in percentage in the inguinal
lymph node (iLN) and blood of both unimmunized young and
aged mice (Figure 1B). The slight increase in TFH cells in blood
of aged mice is likely due to memory cells because we have
shown that blood TFH and TFR cells have characteristics of
memory cells (Sage et al., 2014a). Blood TFH cells in aged hu-
mans express the memory marker CD45RO (Zhou et al., 2014).
TFR cells, defined as CD4+ICOS+CXCR5+FoxP3+CD19 cells,
were similarly low in percentage in the iLN and blood of unimmu-
nized young and aged mice (Figure 1C).
Next, we compared the generation of TFH and TFR cells in
young and aged mice upon antigenic challenge. We immunized
young and aged mice with NP-OVA s.c. and measured TFH and
TFR cell percentages in the draining lymph node (dLN), spleen,
and blood 7 days later. TFH cells were increased 3-fold by per-164 Cell Reports 12, 163–171, July 14, 2015 ª2015 The Authorscentage in the dLN of aged mice compared to young mice after
immunization (Figures 1D and 1E). Similar increases in dLN TFH
cell percentages, but not necessarily total numbers, were found
14 and 27 days after immunization in agedmice (Figures S1A and
S1B). Increased TFH percentages were also found in the blood
and spleen of aged mice (Figures 1E, S1C, and S1D). Serum
cytokine levels were similar in immunized young and aged
mice (Figure S1E), indicating that differences in TFH and anti-
body responses are not due to altered systemic cytokines. Per-
centages of PD-1hi GC-TFH, ICOShi TFH cells, GL7+ GC-TFH,
and Bcl6hi TFHwere also increased in the dLN of agedmice (Fig-
ures S2A–S2D). Therefore, TFH cells are present in agedmice af-
ter immunization.
TFR cell numbers also were increased sharply in the dLNs,
blood, and spleen of aged mice compared to young mice after
immunization (Figures 1D, 1F, and S1A–S1D). We have previ-
ously shown that increases in the TFR:TFH ratio, or the propor-
tion of CXCR5+ cells in the GC that are FoxP3+, correlates with
suppression of antibody responses (Sage et al., 2013, 2014a).
This ratio, calculated as TFR cells as a percentage of total CD4+
CXCR5+ cells, was markedly increased in the dLN of aged mice
(Figure 1G). This increase in TFR percentages of the total CD4+
CXCR5+ pool is partially due to increased total Tregs (which
are TFR precursors) in aged mice (Figure 1H). Thus, in response
to an antigenic stimulus, there is an accumulation of TFR cells
which results in an increase of the TFR:TFH ratio in dLN.
Aged TFR Cells Express More PD-1 and Less ICOS
and Accumulate in Peyer’s Patches
Next, we determined if young and aged TFH and TFR cells were
phenotypically distinct. We found substantial increases in the
level of PD-1 expression on both TFR and TFH cells in aged
mice (Figure 2A). Greater PD-1 expression may inhibit TFR
(and TFH) differentiation, suppressive function, and/or mainte-
nance, because PD-1 suppresses both the differentiation and
suppressive capacity of TFR cells (Sage et al., 2013). Increased
PD-1 expression was not unique to TFH and TFR cells in aged
mice, because CD4+CXCR5 cells also had slightly elevated
PD-1 expression.
The costimulatory molecule ICOS is essential both for the dif-
ferentiation of TFR cells and the differentiation/maintenance of
TFH cells. TFH cells from the dLN had lower ICOS expression
in aged mice compared to young mice (Figure 2B). TFR cells
from the dLN had much lower expression of ICOS in aged
mice than young mice. Decreased ICOS expression may affect
both TFH and TFR cell function. This phenotype was unique to
TFH and TFR cells because ICOS expression did not differ
on CD4+CXCR5FoxP3 cells nor CD4+CXCR5FoxP3+ cells
from the dLN after immunization.
Bcl6 is thought to be the master transcription factor for TFH
cells and is essential for TFR cell differentiation (Linterman
et al., 2011; Nurieva et al., 2009). Bcl6 expression levels were
similar in young and aged TFH and TFR cells, demonstrating
that altered Bcl6 expression in TFH and TFR cells is not res-
ponsible for increased TFH and TFR expansion in aged mice
(Figure 2C). However, both CD4+CXCR5FoxP3 and CD4+
CXCR5FoxP3+ populations in aged mice had significantly
higher levels of Bcl6 compared to young mice, suggesting that
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Figure 1. Increased TFR Cells in Aged Mice
(A) Two-month-old (young) or 20-month-old (aged) mice were immunized s.c. with NP-OVA in CFA and 10 days later sera were collected. Total IgM and IgG (top)
or NP-specific IgM and IgG (bottom) were analyzed with ELISA.
(B and C) Percentages of CD4+ICOS+CXCR5+FoxP3CD19 TFH (B) and CD4+ICOS+CXCR5+FoxP3+CD19 TFR (C) were analyzed in unimmunized young and
aged mice. ILN, inguinal lymph node.
(D–F) Representative plots (D) and quantification of TFH (E) and TFR (F) cells from the draining lymph nodes (dLNs) of young or aged mice 7 days after s.c.
immunization.
(G) Quantification of the TFR contribution to total CD4+CXCR5+ cells (TFR: TFH ratio) in the dLN of young and aged mice 7 days after immunization.
(H) Quantification of total FoxP3+ cells in the dLN of young or agedmice immunizedwith NP-OVA. Data are from five to eightmice per group, and representative of
at least three independent experiments.
Error bars represent SD. See also Figures S1 and S2.higher Bcl6 expression in TFR and TFH precursor cells may lead
to increased differentiation.
Next, we assessed cell death due to previous reports that
aged Tregs had decreased expression of the proapoptotic mole-
cule BIM, which may lead to enhanced Treg survival (Chougnet
et al., 2011). Inhibition of cell death could be one potential expla-
nation for increases in TFR cells in the aged mice. However, cell
death, as measured by active caspase staining with VAD-FMK
was unchanged between young and aged TFH and TFR cells
(Figure 2D). Therefore, we investigated if increased cell cycling
could explain the increase in TFR or TFH cells. Expression of
the cell-cyclemarker, Ki67, was significantly reduced (Figure 2E),
indicating that increased cell cycling is not the reason for the
greater percentages of TFR or TFH cells in aged mice. The
increased Bcl6 expression on TFH and TFR precursors in agedmice, combined with the lack of significant differences in cell
death and lower cell cycling, suggests that over-representation
of TFR and TFH cells in aged mice may be due to increased
TFR and TFH cell differentiation.
Because FoxP3 expression levels may control Treg suppres-
sion and stability (Sakaguchi et al., 2013; Williams and Ruden-
sky, 2007), we also compared FoxP3 expression in TFR cells
from young and aged mice. TFR cells (as well as total Tregs)
from immunized aged mice had slightly attenuated FoxP3 levels
compared to youngmice (Figure 2F), suggesting that TFR cells in
aged mice may have defective suppressive capacity. Together,
these data indicate that TFR cells in aged mice are phenotypi-
cally distinct from TFR cells in young mice, with increased
PD-1, but reduced ICOS and FoxP3 expression, which may alter
their effector functions and/or stability.Cell Reports 12, 163–171, July 14, 2015 ª2015 The Authors 165
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Figure 2. Aged TFR Cells Express More PD-1, Less ICOS, and Accumulate in Peyer’s Patches
(A and B) Comparison of PD-1 expression (A) and ICOS expression (B) on young and aged TFR cells. Expression of PD-1 (A) and ICOS (B) was analyzed on
CD4+ICOSCXCR5 (CXCR5-), CD4+ICOS+CXCR5+FoxP3CD19 (TFH) and CD4+ICOS+CXCR5+FoxP3+CD19 (TFR) cells from dLN of 2-month-old (young) or
20-month old (aged) mice immunized with NP-OVA s.c. 7 days previously. Shaded histogram indicates CXCR5 population.
(C–E) Comparison of intracellular Bcl6 expression (C), cell death by activated caspase staining (D), and cell cycling by Ki67 staining (E) in young and aged TFR and
TFH cells and other populations as in (A).
(F) Comparison of FoxP3 expression in FoxP3+CXCR5 and TFR cells from dLNs of young or aged immunized mice.
(G) TFR and TFH cells in Peyer’s patches (PP). Flow cytometric analysis of total ICOS+CXCR5+ cells in unimmunized young and agedmice (left) and quantification
of TFR cells as a percentage of ICOS+CXCR5+ cells (right).
(H and I) Comparison of ICOS (H) and FoxP3 (I) expression on young and aged TFR cells from PP of unimmunizedmice. Data are from fivemice per group and are
representative of at least two experiments. Error bars indicate SE.
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Besides dLN and blood, TFH and TFR cells can also reside in
Peyer’s patches (PP) of the gut, where they regulate IgA produc-
tion (Kawamoto et al., 2014; Sage et al., 2014b; Tsuji et al., 2009).
We found a substantial population of TFH cells in PP of unimmu-
nized young and aged mice, and similar percentages (Figure 2G
anddata not shown). There alsowasaconsiderable population of
TFRcells in thePPof both youngandagedmice (Figure 2G), but a
proportional increase in TFR cells in the total CXCR5+CD4+ T cell
pool inPPof agedmicecompared to youngmice (Figure 2G). This
over-representation of TFR cells in PPmay lead to lower IgA pro-
duction and contribute to a change in microbiota in the gut of
aged animals because altered TFR:TFH ratios may change mi-
crobiota (Kawamoto et al., 2014). ICOS expression was signifi-
cantly attenuated onPPTFR cells and reduced to a lesser degree
on PP TFH cells of aged mice (Figure 2H). However, FoxP3
expression was similar in aged and young TFR cells in PP (Fig-
ure 2I). Taken together, these studies indicate that TFR cells are
proportionally increased in PP as well as dLN cells of aged
mice; this increase may alter T-cell-dependent antibody produc-
tion in aged mice.
Aged TFH Cells Have Less Antigen-Specific Stimulatory
Capacity
Next, we investigated TFH cell function in aged mice because
immunosenescence has been postulated to cause cell-intrinsic
defects in effector cells in aging. We first used antigen-non-spe-
cific in vitro B cell class switch recombination assays that we
developed (Sage et al., 2014a, 2014b; Sage and Sharpe,
2015). These assays sensitively assess cell-intrinsic TFH effector
function separately from TFH differentiation and do not depend
on the antigen specificity of the TFH cells. We sorted TFH
cells as CD4+ICOS+CXCR5+GITR-CD19 from dLNs of young
(2 month old) or aged (20 month old) mice that were immunized
with NP-OVA s.c. 7 days previously. Importantly, GITR expres-
sion was comparably low on aged and young TFH cells (Fig-
ure S3A). These TFH cells were cultured with young CD19+ B
cells (also isolated from dLNs) along with anti-IgM and anti-
CD3. Surprisingly, young and aged TFH cells similarly stimulated
B cells to class switch to IgG1 (Figure 3A). Next, we examined
expression of the GC and activation marker GL7 on B cells
because GL7 expression is a sensitive marker for B cell activa-
tion in these assays (Sage et al., 2014a). GL7 was similarly upre-
gulated on B cells when either young or aged TFH cells were in
the cultures (Figure 3A). Intracellular Bcl6 and Ki67 expression
also were similar in young and aged TFH cells following culture
with B cells (Figure 3B). These unexpected findings suggest
that young and aged TFH cells have comparable stimulatory ca-
pacity in these antigen non-specific assays. Thus, although
many defects have been seen in the CD4+ T cell compartment
with advancing age, TFH cells from young and agedmice appear
to have similar cell-intrinsic capacity to participate in B cell help.
The similar stimulatory function of young and aged TFH cells
was perplexing given the defective antibody production in immu-
nized agedmice.We hypothesized that TFH cells fromagedmice
maybe functional, butexhibit antigen-specificdefects.To test this
hypothesis,weadaptedour in vitro assays toassessantigen-spe-
cific responses. We cultured young B cells with young or aged
TFH cells (sorted from dLNs of NP-OVA immunized mice) alongwith NP-OVA for 6 days andmeasured B cell class switch recom-
bination. Aged TFH cells stimulated B cells to undergo class
switch recombination slightly less well to IgG1 and substantially
less well to IgG2a, compared to young TFH cells (Figure 3C).
Moreover, a slightly lower percentage of aged TFH cells ex-
pressed Bcl6 and Ki67 expression compared to young TFH cells
(Figure3D).Therefore, in theseantigen-specific in vitrostimulation
assays, aged TFH cells showed modest deficits in B cell help,
leading to a small reduction in antibody production by the B cells.
Because PD-1 is more highly expressed on aged TFH cells
compared to young TFH cells and PD-1 blockade can enhance
CD4+ T cell cytokine production and CD8+ proliferation in aged
mice (Lages et al., 2010; Mirza et al., 2010), we next tested
whether PD-1 pathway blockade could overcome some of the
age-related defects in TFH cell function. Anti-PD-L1 blocking
monoclonal antibodies substantially enhanced the stimulatory
capacity of aged TFH cells in antigen-specific B cell stimulation
assays (Figure 3E). Thus, aged TFH cells show defects in activa-
tion following antigen-specific stimulation, and PD-L1 blockade
can improve the function of the antigen-specific TFH cells.
Next, we determined whether aged TFH cells had less stimu-
latory capacity in vivo using an adoptive transfer approach. We
immunized young or aged mice with NP-OVA, and 7 days later
sorted TFH cells from dLNs and transferred them to young
CD28/ mice (which cannot generate TFH and TFR cells) and
immunized them with NP-OVA. Aged TFH cells stimulated mark-
edly less GC B cell differentiation and plasma cell formation, as
well as significantly less NP-specific antibody production in vivo
compared to young TFH cells in transfer recipients at day 10
post-transfer and immunization (Figures 3F–3H). The differences
in GC B cells persisted until 20 days after transfer, but plasma
cell percentages did not (Figure S3B). Thus, there were much
greater defects in the capacity of aged TFH cells to support B
cell responses in vivo compared to in vitro, likely reflecting
increased requirements for proliferation in vivo than in vitro. In
support of this, more young TFH cells persisted in vivo after
transfer compared to aged TFH cells. (Figure S3C). In addition,
it is possible that TFH and/or B cells have a higher threshold
for activation in vivo than in our in vitro assays.
Aged TFR Cells Have Potent Suppressive Capacity
Next, we compared the suppressive function of young and aged
TFR cells because TFR cells predominate in aged mice and
appear to be phenotypically distinct from young TFR cells. First,
we cultured young or aged dLN TFR cells with young dLN TFH
and B cells using in vitro non-antigen-specific assays, and stim-
ulated the cells with anti-CD3 and anti-IgM, as in Figure 3A.
Young and aged TFR cells potently suppressed class switch
recombination to IgG1 to a similar extent (Figures 4A and 4B).
Young and aged TFR cells attenuated GL7 expression on B cells
almost to the level of unstimulated B cells and comparably sup-
pressed young TFH cells, as evidenced by the similar reduction
in Ki67 expression in TFH cells (Figure 4C). In addition, a similarly
high proportion of young and aged TFR cells were in cell cycle in
these cultures (Figure 4D). The ratios of TFH and TFR cells in
these cultures also were roughly similar (Figure S4). Thus, TFR
cells from young and aged mice have similar and potent intrinsic
capacity to inhibit B cell responses. Because TFR cells areCell Reports 12, 163–171, July 14, 2015 ª2015 The Authors 167
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Figure 3. Aged TFH Cells Have Defective Capacity to Stimulate Antigen-Specific Antibody Production
(A) Non-antigen-specific antibody stimulation assays. CD4+ICOS+CXCR5+GITRCD19 (TFH) cells sorted from 2-month-old (young) or 20-month-old (aged)
mice immunized with NP-OVA s.c. 7 days previously were cultured with CD19+ B cells from dLN of similarly immunized youngmice along with anti-CD3 and anti-
IgM for 6 days. B cells were surface stained for GL7 and intracellularly stained for IgG1. Plots are pre-gated on CD19+IA+ B cells.
(B) Ki67 and Bcl6 staining of TFH cells from assays as in (A).
(C) Cells sorted as in (A) were cultured with NP-OVA for 6 days, and IgG1+GL7+ cells were analyzed as in (A).
(D) Ki67 and Bcl6 staining of young or aged TFH cells from assays as in (C).
(E) Aged TFH cells were cultured with young B cells and NP-OVA as in (C) in the presence of anti-PD-L1 or isotype control.
(F–H) Comparison of B cell responses mediated by young and aged TFH cells in vivo. Young or aged TFH cells were sorted from mice immunized with NP-OVA
7 days previously and transferred to CD28/ recipients that were immunized. Ten days later, dLNs were analyzed for GC B cells (F) and plasma cells (G), and (H)
serum for NP-specific antibody titers.
Data are from replicate wells (A, C, and E), and representative of at least two (E) or three (A and C) experiments. In vivo experiments are from ten pooled mice per
condition and transferred into a single mouse recipient, and representative of three independent experiments. See also Figure S3.greatly expanded in agedmice and these cells have suppressive
capacity comparable to young TFR cells, the increase in TFR cell
proportions in agedmice is amajor reason for defective B cell re-
sponses in vivo.
Next, we analyzed TFR cell function using antigen-specific
in vitro assays. Aged and young TFR cells had virtually the168 Cell Reports 12, 163–171, July 14, 2015 ª2015 The Authorssame ability to suppress class switch recombination to IgG1
when NP-OVA was added to the cultures (Figure 4E). However,
therewas a significant decrease in suppression of class switched
IgG2a+ GL7+ B cells by aged TFR cells compared to young TFR
cells, albeit this difference of 0.3% is very minor (Figure 4F).
Aged and young TFR cells similarly suppressed Ki67 expression
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Figure 4. Aged TFR Cells Potently Suppress TFH Cell-Mediated Antibody Production
(A) TFR cell antigen non-specific suppression assays. Sorted CD4+ICOS+CXCR5+GITR+CD19 (TFR) cells from 2-month-old (young) or 20-month-old (aged)
mice immunized with NP-OVA s.c. 7 days previously were cultured with young B cells and young TFH cells and anti-CD3 plus anti-IgM.
(B) Quantification of IgG1+GL7+ cells in plots in (A).
(C and D) Intracellular Ki67 staining of FoxP3 TFH cells and (D) intracellular Ki67 staining of FoxP3+ TFR cells from young TFR (red) or aged TFR (gray) in cultures
described in (A).
(E–I) Cells sorted as in (A) were cultured with TFH and B cells from young mice along with NP-OVA. Six days later, B cells were stained for surface GL7 or
intracellular IgG1 (E) or IgG2a (F). B cells were identified as CD19+IA+. CD4+FoxP3 TFH from cultures as in (E) were stained intracellularly for Ki67(G) or (H)
interferon gamma and interleukin-17A (E). (I) Young (red) or aged (gray) TFR cells from cultures as in (E) were stained intracellularly for Ki67.
(J) In vivo TFR cell suppression assay. Young TFH and young or aged TFR cells (from mice immunized with NP-OVA 7 days previously) were transferred to
CD28/ mice that were immunized with NP-OVA. Ten days later, serum was analyzed for NP-specific IgG.
(K) In vivo functional assay of TFH and TFR cells from young or aged mice. Total CD4+CXCR5+ICOS+CD19 cells from young or aged mice immunized with NP-
OVA 7 days previously were transferred to CD28/ mice that were immunized with NP-OVA. Ten days later, serum was analyzed for NP-specific IgG.
Data are from replicate wells and are representative of three independent experiments (A–I), representative of two independent experiments (J), or combined data
from three independent experiments (K). See also Figure S4.
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(Figure 4G) and interferon-gamma production by TFH cells
(Figure 4H). In addition, young and aged TFR cells similarly
expressed Ki67 at the end of the suppression assay (Figure 4I).
These data suggest that young and aged TFR cells are
similarly stimulated by B cells and have comparable suppressive
function.
Next, we compared the ability of young and aged TFR cells to
suppress antigen-specific antibody responses in vivo. We adop-
tively transferred young TFH cells along with young or aged TFR
cells (all sorted from immunized mice) to CD28/ recipients,
immunized these recipients with NP-OVA, and assessed anti-
gen-specific antibody levels in the serum 10 days later. Aged
TFR cells suppressed antigen-specific antibody levels to the
same degree as young TFR cells (Figure 4J).
BecauseagedTFHcellshavedefects inBcell stimulation invivo
and aged TFR cells are equally suppressive in vivo, we next used
adoptive transfer approaches to compare the young versus aged
CXCR5+ populations in their endogenous ratios. This approach
enables us to determine the consequences of the altered function
of aged TFH cells together with themarked increases in TFR cells
in aged mice on antibody production in vivo. We sorted total
CD4+CXCR5+CD19 cells fromyoungor agedmiceonday7after
immunization with NP-OVA, and transferred these cells (preser-
ving their endogenous proportions) into CD28/ recipients that
were then immunized with NP-OVA. Ten days later, we assessed
antigen-specificantibody levels in serum.Thereweresignificantly
higher levels of NP-specific IgG in the sera of recipients of total
TFH and TFR cells from young mice compared to recipients of
aged TFH and TFR cells (Figure 4K). These results show that
defective antibody responses in aged mice are due, at least in
part, to the combination of defective TFH cell function and higher
proportions of TFR cells in aged mice.
Together, our studies provide insights into mechanisms for
defective antibody production in aging. We find an over-repre-
sentation of functionally competent suppressive TFR cells in
aged mice, most likely resulting from enhanced differentiation
of TFR cells. However, expansion of memory TFR cells may
also contribute. In addition, we find that TFH cells are generated
following immunization of aged mice, but these aged TFH cells
fail to elicit strong antigen-specific B cell responses in vivo.
Aged TFH cells express higher levels of PD-1 and PD-1 blockade
can improve TFH cell function. Thus, the substantial increase in
fully suppressive TFR cells, combined with the decrease in anti-
gen-specific responses of TFHcells, results in a significant defect
in antibody production in aged mice. Although other mecha-
nisms, such as defects in clonality and/or naive T or B cell
numbers also may contribute, our data point to alterations in
TFH cell activity and TFR cell proportions as being a key mecha-
nism that impairs antibody production in aging. Therefore, ap-
proaches that downmodulate TFR cells may provide a strategy
for improving humoral immune responses in the elderly.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were obtained from the National Institute of Aging or The Jack-
son Laboratory. Young mice were 8 weeks old and aged mice were 20 months
old. CD28/mice were purchased from The Jackson Laboratory. Animal pro-170 Cell Reports 12, 163–171, July 14, 2015 ª2015 The Authorstocols were approved by the Harvard Medical School Standing Committee on
Animals.
Immunizations
For standard NP-OVA immunizations, 100 mg NP18-OVA (Biosearch Technol-
ogies) in a 1:1 H37RA CFA (DIFCO) emulsion was injected s.c. into the flanks of
young or aged mice. The spleen, dLN, and blood were harvested 7–27 days
later. PP were harvested from unimmunized mice. Serum was isolated from
blood using serum separator tubes (BD vacutainer) and NP-specific IgG
measured by ELISA as previously described (Sage et al., 2013).
Flow Cytometry
Cells were harvested and stained with directly labeled antibodies (as detailed
in the Supplemental Experimental Procedures). For intracellular staining, the
FoxP3 fix/perm kit was used (eBioscience). For VAD-FMK staining, the Casp-
glow kit was used (eBioscience). For intracellular cytokine staining, cells were
incubated with 1 mg/ml ionomycin (Sigma) and 500 ng/ml PMA (Sigma) in the
presence of Golgistop (BD biosciences) for 4 hr prior to staining.
Adoptive Transfers
For TFH cell transfers, ten young or aged mice were immunized, and 7 days
later, dLN were harvested; 2 3 105 CD4+ICOS+CXCR5+GITRCD19 TFH
cells were sorted and transferred to CD28/mice that were then immunized.
Ten days later, the dLNs and sera were harvested. For young and aged TFR
transfers, 1 3 105 TFH and 2.5 3 104 young or aged CD4+ICOS+CXCR5+
GITR+CD19 TFR cells were sorted and transferred to CD28/ mice, which
were immunized. For total CXCR5+ cell transfers, 7.5 3 104 young or aged
sorted CD4+CXCR5+ICOS+CD19 cells were transferred to CD28/ mice,
which were immunized.
In Vitro Suppression Assay
For non-antigen-specific TFH stimulation assays, 3 3 104 dLN CD4+
ICOS+CXCR5+CD19-GITR TFH cells from young or aged mice were plated
with 5 3 104 CD19+ young B cells (all purified from dLNs of immunized
mice) and 2 mg/ml soluble anti-CD3 (2C11, BioXcell) plus 5 mg/ml anti-IgM
(Jackson Immunoresearch) for 6 days. Antigen-specific assays were per-
formed similarly, except 20 mg/ml NP-OVA was added to the cultures instead
of anti-CD3/IgM. In some assays, 20 mg/ml of anti-PD-L1 (clone 10F.9G2) or
isotype control was added. For TFR cell suppression assays, 1.5 3 104 CD4+
ICOS+CXCR5+CD19-GITR+ TFR cells from the dLN of young or aged immu-
nized mice were added to the wells along with TFH and B cells. Cells were
harvested and analyzed 6 days later.
Statistical Analysis
Unpaired Student’s t test was used for all comparisons and data are repre-
sented as mean ± SD or SE. p Values <0.05 were considered statistically sig-
nificant. *p < 0.05, **p < 0.005, ***p < 0.0005.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.06.015.
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